Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-K for the period ended Dec 31, 2017

Filed with the SEC on Apr 16, 2018 and accepted by EDGAR at Apr 16, 2018, 19:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Current assetsAt period end2017-12-31$33.6kus-gaap:AssetsCurrent
Total assetsAt period end2017-12-31$250.0kus-gaap:Assets
Current liabilitiesAt period end2017-12-31$3.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-12-31$5.3mus-gaap:Liabilities
Short-term borrowingsAt period end2017-12-31$253.0kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2017-12-31−$5.0mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001213900-18-004509. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.